Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2000-01-06
2001-04-10
Lilling, Herbert J. (Department: 1651)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S059000, C424S062000, C424S401000
Reexamination Certificate
active
06214352
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to tyrosinase-inhibiting agents and further specifically relates to tyrosinase-inhibiting agents containing extracts or fractions prepared from Gardenia fruit, Sophora root, and Rosa fruit as the active ingredients. The tyrosinase-inhibiting agents of this invention may be used for improving the skin color and the like.
2. Description of the Related Art
Tyrosine, which is a type of amino acid, is converted by the action of tyrosinase enzyme into melanin, a black-brown to red-brown pigment, which is the cause of skin blemishes and spots. In order to prevent the production of melanin under the action of tyrosinase, various compounds have been used or proposed to inhibit the activity of tyrosinase in the fields of cosmetics and foods.
Representative examples of such compounds are ascorbic acid, sulfur compounds, hydroquinone, kojic acid, and natural plant extracts.
Ascorbic acid suffers from stability problems in the presence of moisture, while sulfur compounds have odor problems. Hydroquinone has a very high degree of efficacy, but has the shortcoming being highly toxic. Kojic acid and natural plant extracts have a high degree of safety but have weak tyrosinase-inhibiting activity, and in addition plant extracts often have odor and color problems.
In the recent years in view of the heightened interest by the society in cosmetics with a high degree of safety in promoting health, there is a need for tyrosinase-inhibiting agents which inhibit melanin production, which could be widely used in cosmetics, which are derived from natural products of high degree of safety, and which do not adversely affect the quality of the final product from the standpoint of taste or odor.
Japanese Patent Application Publications Showa 50-135236, Showa 60-104005, Showa 64-26507, Heisei 3-193712, Heisei 6-65045, Heisei 6-128143, Heisei 6-336418, Heisei 8-99859, Heisei 6-336418 and Heisei 8-99859 describe extracts of Gardenia, Sophora and Rosa which have tyrosinase-inhibiting activity.
Japanese Patent Application Publications Heisei 3-157334, Heisei 7-61915, Heisei 7-25762, and Heisei 5-139950 describe the uses of extracts of Gardenia, Rosa, or Sophora plants in the prevention and treatment of skin blemishes.
Japanese Patent Application Publications Heisei 10-279462, Heisei 10-279460, Heisei 10-265322, Heisei 10-265321, Heisei 10-182404, Heisei 10-330217 describe the use of Rosa or Sophora plant extracts as tyrosinase-inhibiting agents.
However, none of these show effective efficacy as a tyrosinase-inhibiting agent.
SUMMARY OF INVENTION
The present invention is aimed at proposing a novel tyrosinase-inhibiting agent which satisfies the need.
In order to achieve this objective, the present invention proposes a tyrosinase-inhibiting agent containing as the active ingredients three types of extracts obtained by extracting the Gardenia jasminoides fruit, Sophora flavescens root and Rosa multiflora fruit with an aqueous or hydrophilic solvent or a mixture thereof.
For example, if the tyrosinase-inhibiting agent is to be composed entirely of these three extracts, it is preferable that the Gardenia extract be present in the range of 15-30%, Sophora extract in the range of 15-20%, and Rosa extract in the range of 40-70%.
The present invention further proposes cosmetics which contain the three types of extracts made from the Gardenia, Sophora and Rosa.
The cosmetics contain, for example, Gardenia extract in the range of 15-30%, Sophora extract in the range of 15-30%, and Rosa extract in the range of 40-70%.
Through the use of the present invention, it is possible to propose a tyrosinase-inhibiting agent which can be widely used in cosmetics, which is made of highly safe natural products, and which do not adversely affect the quality of the final product from the standpoint of taste or odor.
The above and other objectives and advantageous features of the present invention will be made apparent from the description made with reference to the accompanying drawings, in which like reference characters designate the same or similar parts throughout the drawings.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Preferred embodiments in accordance with the present invention will be explained herein below with reference to drawings.
Gardenia jasminoides is a plant in the Rubiaceae family, and its fruit has been used as Kampo medicinal herb as an antipyretic, anti-inflammatory and hemostatic drug.
Sophora flavescens is a plant in the Leguminosae family and has been used as astringent/cathartic drug. It has also been used in cosmetics as an anti-microbial agent.
Rosa multiflora is the multiflora rose of the Rosaceae family, the mature fruit of which when dried has been used as a cathartic agent and diuretic. In cosmetics, it has been used as an antimicrobial agent.
The Gardenia fruit, Sophora root and Rosa fruit are ground in an appropriate manner and extracted using as the solvent of water, hydrophilic organic solvent or a mixture thereof. Organic solvents used for extraction are most appropriately especially, lower alcohols such as methanol and ethanol, and polyvalent alcohols such as 1,3-butylene glycol. The method of extraction is not particularly restricted, and the active ingredients can be extracted by immersing in the solvent maintained at room temperature to a temperature near the boiling point.
The tyrosinase-inhibiting agent of this invention when used as a mixture of 15-30% as Gardenia extract, 15-30% Sophora extract and 40-65% Rosa extract has an efficacy that is better than the product containing a single component.
When the tyrosinase-inhibiting agent of the present invention is used in cosmetics, it may be used in combination with other appropriate agents such as physiologically active agents which are generally used as components of cosmetics, for example astringents, antimicrobial agents and disinfectants, whitening agents, ultraviolet light absorbing agents, moisturizing agents, cell activating agents, anti-inflammatory and anti-allergy agents, anti-oxidant and activated oxygen removing agents. In such cases, synergistic effects with other effective ingredients may give effects which are superior to the normally expected degree of efficacy.
Specific examples of cosmetic components which can be used with the tyrosinase-inhibiting agents of this invention are as follows.
Astringents: citric acid or its salts, tartaric acid or its salts, aluminum chloride, aluminum sulfate, potassium sulfate, Ficus extract, Hamamelis extract, Geranium extract, Artemisia extract, Salvia extract, Aesculus extract, Equisetum extract, Melissa extract, and the like.
Antimicrobials and disinfectants: benzoic acid, sodium benzoate, benzetonium chloride, salicylic acid, sodium salicylate, sorbic acid, resorcin, bisabolol, hinokitiol, menthol, chitosan, Kalimeris extract, Eriobotrya extract, Yucca extract, Aloe extract, and the like.
Whitening agents: Ascorbic acid and its derivatives, sulfur, kojic acid and its derivatives, glucosamine and its derivatives, glutathione, Arnica extract, Scutellaria root extract, Morus extract, Bupleurum extract, Coix extract, Aesculus extract, oil-soluble Glycyrrhizae extract (Glycyrrhizae hydrophobic flavones, glabridin, glabrene, licochalcone A) and the like.
Ultraviolet absorbing agents: beta-isopropyl furanone derivatives, urocanic acid, oxybenzone, para-aminobenzoic acid, octyl methoxycinnamate, titanium oxide, beta-carotene, gamma-oryzanol, Aloe extract, rice bran extract, Chamomile extract, Crataegus extract, and the like.
Moisturizing agents: serine, glycine, alanine, collagen, hydrogenated collagen, keratin, elastin, royal jelly, chondroitin heparin, pectin, bifidobacterium fermentation products, Lactobacillus fermentation products, yeast extract, jojoba oil, Coix extract, Rehmannia extract, Zizyphus extract, Aloe arborescens extract, burdock extract, and the like.
Cell stimulating agents: Riboflavin and its derivatives, pyridoxine and its derivatives, nicotinic acid and its derivatives, pantothenic acid and its deri
Griffin & Szipl, P.C.
Lilling Herbert J.
Matsukawa Kagaku Co., Ltd.
LandOfFree
Tyrosinase inhibiting agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosinase inhibiting agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosinase inhibiting agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2467097